With a solid product portfolio, strong market position, and a focus on electric vehicles, the company is expected to outperform the industry Read More With a solid product portfolio, strong market position, and a focus on electric vehicles, the company… Read More »TVS Q3FY24: Strong quarter, valuation at elevated levels
Under the agreement, Glenmark will get the license for KN035 (Envafolimab) in India, Asia Pacific, the Middle East, Africa, Russia, CIS, and Latin America, the company said in a statement. Read More Under the agreement, Glenmark will get the license… Read More »Glenmark inks licensing pact with Jiangsu Alphamab, 3D Medicines for cancer drug
Strategic initiatives to introduce new products and expand market share Read More Strategic initiatives to introduce new products and expand market share Strategic initiatives to introduce new products and expand market share Moneycontrol Latest News Read More Strategic initiatives to introduce new… Read More »Bajaj Auto Q3 FY24: Premium products helping, valuation expensive
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
English 
हिन्दी